Drug Coverage

Latest News

Analysis: Farxiga is a High-Value Medication for Patients with Heart Failure
Analysis: Farxiga is a High-Value Medication for Patients with Heart Failure

September 29th 2023

The recent study also found that Jardiance for patients with heart failure with preserved ejection fraction could be cost-effective if discounted by 29%.

Class Action Lawsuit Filed Against CVS Caremark to Recoup DIR Fees
Class Action Lawsuit Filed Against CVS Caremark to Recoup DIR Fees

September 27th 2023

Preservative-free Therapy Launches to Reduce Intraocular Pressure in Glaucoma
Preservative-free Therapy Launches to Reduce Intraocular Pressure in Glaucoma

September 26th 2023

ICER Adds New Measures of Value to its Assessment Framework
ICER Adds New Measures of Value to its Assessment Framework

September 25th 2023

Study Finds Racial Disparities in Copay Adjustment Programs
Study Finds Racial Disparities in Copay Adjustment Programs

September 21st 2023

More News

© 2023 MJH Life Sciences

All rights reserved.